摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2,3,10,11,11a(S)-hexahydro-5H-pyrrolo<2,1-c>pyrido<3,2-f><1,4>oxazepin-5-one | 100044-96-0

中文名称
——
中文别名
——
英文名称
1,2,3,10,11,11a(S)-hexahydro-5H-pyrrolo<2,1-c>pyrido<3,2-f><1,4>oxazepin-5-one
英文别名
(S)-8,9,9a,10-tetrahydropyrido[3,2-f]pyrrolo[2,1-c][1,4]oxazepin-5(7H)-one;1,2,3,10,11,11a(S)-hexahydro-5H-pyrrolo[2,1-c]pyrido-[3,2-f][1,4]oxazepin-5-one;(3S)-3,4-Propano-2,3-dihydropyrido[3,2-f][1,4]oxazepine-5(4H)-one;(7S)-9-oxa-3,11-diazatricyclo[8.4.0.03,7]tetradeca-1(10),11,13-trien-2-one
1,2,3,10,11,11a(S)-hexahydro-5H-pyrrolo<2,1-c>pyrido<3,2-f><1,4>oxazepin-5-one化学式
CAS
100044-96-0
化学式
C11H12N2O2
mdl
——
分子量
204.228
InChiKey
FIKUEZUFASUKAH-QMMMGPOBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    15
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    42.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Organobase-Catalyzed Amidation of Esters with Amino Alcohols
    作者:Nicola Caldwell、Craig Jamieson、Iain Simpson、Tell Tuttle
    DOI:10.1021/ol400987p
    日期:2013.5.17
    A base-mediated procedure for the amidation of unactivated esters with amino alcohols is reported. Optimization and exemplification of the catalytic process are described, furnishing products in 40–100% isolated yield.
    据报道,用碱介导的方法将未活化的酯与基醇酰胺化。描述了催化过程的优化和实例,以40-100%的分离产率提供了产品。
  • Regio- and stereoselective control in the addition of Grignard reagents to the pyridine ring system
    作者:Arthur G. Schultz、Lawrence Flood、James P. Springer
    DOI:10.1021/jo00356a016
    日期:1986.3
  • SCHULTZ, A. G.;FLOOD, L.;SPRINGER, J. P., J. ORG. CHEM., 1986, 51, N 6, 838-841
    作者:SCHULTZ, A. G.、FLOOD, L.、SPRINGER, J. P.
    DOI:——
    日期:——
  • Modulation of AMPA/kainate Receptors for the Treatment of Hypoglycemia
    申请人:Vanderklish Peter
    公开号:US20200397751A1
    公开(公告)日:2020-12-24
    Methods for modulating the levels of glucagon and blood glucose of a mammal are provided. In the subject methods, a positive allosteric modulator of AMPA/kainate receptors is administered to a host. The subject methods find use in applications where it is desired to increase one or both of the glucagon and blood glucose levels in a mammalian host. The subject methods find use in applications where it is desired to decrease the size, or breadth, of the circadian range of blood glucose levels in a mammalian host. The subject methods also find use in applications where it is desired to decrease the frequency, severity, or occurrence of hypoglycemia in a mammalian host. Finally, the subject method finds use in applications where it is desired to decrease the frequency, severity, or occurrence of nocturnal hypoglycemia in a mammalian host, particularly that which occurs in diabetics as a result of therapy with insulins or insulin analogs or other glucose lowering agents, or combinations of such agents.
查看更多